President Joe Biden is expected to mark 500,000 U.S. lives lost from COVID-19 with a moment of silence and candle-lighting ceremony at the White House.
The country is expected to pass the grim milestone on Monday, just over a year after the first confirmed U.S. fatality of the pandemic.
The White House said Biden will deliver remarks at sunset to honour those who lost their lives. He will be joined by his wife, Jill Biden, and Vice-President Kamala Harris and her husband, Doug Emhoff. They will participate in the moment of silence and lighting ceremony.
Biden has made a point of recognizing the lives lost from the coronavirus. His first event upon arriving in Washington for his inauguration a month ago was to deliver remarks at a COVID-19 memorial ceremony.
A tally maintained by Johns Hopkins University put the number of recorded COVID-19 cases in the U.S. at more than 28.1 million as of late Monday morning, with a death toll of more than 499,000.
Hospitalizations, however, have been declining in the hard-hit country, which has been working to scale up vaccination efforts.
The White House said about a third of the coronavirus vaccine doses delayed by this week’s winter weather have been delivered this weekend.
Press Secretary Jen Psaki said the administration has been working with shippers and states to close the roughly six-million dose backlog created this week as power outages closed some vaccination centres and icy weather stranded some vaccine in shipping hubs.
Speaking to ABC’s This Week, Psaki said: “We’ve been able to get about two million of those six million doses out,” noting, “We expect to rapidly catch up this week.”
-From The Associated Press, last updated at 10:53 a.m. ET
What’s happening across Canada
WATCH | Nova Scotia moves into next stage of vaccine rollout:
As of 11:15 a.m. ET on Monday, Canada had reported 847,520 cases of COVID-19, with 31,173 cases considered active. A CBC News tally of deaths stood at 21,696.
Ontario on Monday reported 1,058 new cases of COVID-19 and 11 additional deaths. Hospitalizations of COVID-19 patients stood at 646, with 280 people in intensive care units.
Ontario is reporting 1,058 cases of <a href=”https://twitter.com/hashtag/COVID19?src=hash&ref_src=twsrc%5Etfw”>#COVID19</a> and nearly 31,200 tests completed. Locally, there are 325 new cases in Toronto, 215 in Peel and 87 in York Region. <br> <br>As of 8:00 p.m. yesterday, 569,455 doses of the COVID-19 vaccine have been administered.
One of Ontario’s long-standing COVID-19 hot spots returns to the province’s colour-coded system of pandemic restrictions while a stay-at-home order remains in effect for three others. Businesses in York Region are allowed to reopen as the public health unit returns to the second-most restrictive red level of public health precautions.
Non-essential retailers and restaurants can welcome customers back, with capacity limits and physical distancing in place.
York has long logged some of Ontario’s highest COVID-19 case counts, but the region’s chief medical officer of health requested that the province move it back to the tiered framework to bring it in line with most of Ontario’s other public health units. The stay-at-home order remains in effect only for Toronto, Peel and North Bay-Parry Sound until at least March 8.
Across Atlantic Canada, Prince Edward Island opened its first community COVID-19 vaccination clinic on Monday. The clinic is for people over 80 who don’t live in retirement homes or long-term care facilities. Nova Scotia is also expanding its vaccination efforts with a prototype clinic for people aged 80 and up at the IWK Health Centre in Halifax.
In Newfoundland and Labrador, health officials reported 25 new cases of COVID-19 on Sunday, bringing the total number of active cases in the province to 430. All of the cases were in the Eastern Health region, which includes St. John’s. Health officials said there was also one presumptive positive case awaiting confirmation.
COVID-19 hospitalizations stood at three, according to a provincial dashboard.
New Brunswick reported four new cases of COVID-19 on Sunday. Health officials in New Brunswick confirmed the death of a person in their 80s at the Manoir Belle Vue, an adult residential facility in Edmundston. The province has now logged a total of 25 deaths related to the novel coronavirus.
In Quebec, health officials reported 805 new cases of COVID-19 and 11 additional deaths on Monday. Hospitalizations stood at 689, with 117 COVID-19 patients in the province’s intensive care units, a provincial dashboard updated Monday said.
In the Prairie provinces, Manitoba reported 58 new cases of COVID-19 and two additional deaths on Sunday. Meanwhile, Saskatchewan reported 182 new cases of COVID-19 and four additional deaths. Alberta, meanwhile, reported 328 new cases and nine additional deaths.
In British Columbia, health officials will provide updated COVID-19 figures later Monday.
Across the North, there was one new case of COVID-19 reported in Nunavut on Sunday, and there were no new cases reported in the Northwest Territories and Yukon.
WATCH | Ottawa confident provinces are ready for flood of vaccines:
Here’s a look at what’s happening across the country:
-From CBC News and The Canadian Press, last updated at 11:15 a.m. ET
What’s happening around the world
As of early Monday morning, more than 111.4 million cases of COVID-19 had been reported worldwide, with 62.8 million of those listed as recovered or resolved on a tracking site maintained by Johns Hopkins University. The global death toll stood at more than 2.4 million.
GlaxoSmithKline and Sanofi on Monday said they had started a new clinical trial of their protein-based COVID-19 vaccine candidate, reviving their efforts against the pandemic after a setback in December delayed the shot’s launch.
In December, the two groups stunned investors when they said their vaccine would be delayed toward the end of 2021 after clinical trials showed an insufficient immune response in older people.
GSK and Sanofi’s vaccine candidate uses the same recombinant protein-based technology as one of Sanofi’s seasonal influenza vaccines. It will be coupled with an adjuvant, a substance that acts as a booster to the shot, made by GSK.
“Over the past few weeks, our teams have worked to refine the antigen formulation of our recombinant-protein vaccine,” Thomas Triomphe, executive vice-president and head of Sanofi Pasteur, said in a statement.
The new mid-stage trial will evaluate the safety, tolerability and immune response of the vaccine in 720 healthy adults across the United States, Honduras and Panama and test two injections given 21 days apart.
Sanofi and GSK have secured deals to supply their vaccine to the European Union, Britain, Canada and the United States. It also plans to provide shots to the World Health Organization’s COVAX program.
To appease critics after the delay, Sanofi said earlier this year it had agreed to fill and pack millions of doses of the Pfizer-BioNTech vaccine from July.
Sanofi is also working with Translate Bio on another COVID-19 vaccine candidate based on mRNA technology.
In Europe, British Prime Minister Boris Johnson announced a slow easing of one of Europe’s strictest pandemic lockdowns on Monday, saying children will return to class and people will be able to meet a friend outside for coffee in two weeks’ time.
But those longing for a haircut, a restaurant meal or a pint in a pub have almost two months to wait, and people won’t be able to hug loved ones they don’t live with until May at the earliest.
Johnson said the government’s plan would move the country “cautiously but irreversibly” out of lockdown.
Britain has had Europe’s deadliest coronavirus outbreak, with more than 120,000 deaths. Faced with a dominant virus variant that scientists say is both more transmissible and more deadly than the original virus, the country has spent much of the winter under a tight lockdown. Bars, restaurants, gyms, schools, hair salons and nonessential shops are closed, people are urged not to travel out of their local area and foreign holidays are illegal.
That will begin to change, slowly, on March 8, when schools reopen and people are allowed to meet one friend or relative for a chat or picnic outdoors. Three weeks later, people will be able to meet in small groups outdoors for sports or relaxation.
Under the government plan, shops and hairdressers will reopen April 12. So will pubs and restaurants, although only outdoors. Indoor venues such as theatres and cinemas, and indoor seating in bars and restaurants, are scheduled to open May 17, and limited crowds will be able to return to sports stadiums. It is also the earliest date Britons may be allowed foreign holidays.
The final stage of the plan, in which all legal limits on social conduct are removed, is set for June 21. The government says the dates could all be postponed if infections rise.
The measures being announced apply to England. Scotland, Wales and Northern Ireland all have slightly different lockdowns in place, with some children returning to class in Scotland and Wales on Monday.
Hopes for a return to normality rest largely on Britain’s fast-moving inoculation program that has given more than 17.5 million people, one-third of the country’s adult population, the first of two doses of vaccine. The aim is to give every adult a shot of vaccine by July 31, and to protect the over 50s and the medically vulnerable by getting them a first vaccine jab by April 15.
But the government cautions that the return of the country’s social and economic life will be slow.
Elementary schools and kindergartens in more than half of Germany’s 16 states reopened Monday after two months of closure because of the coronavirus pandemic.
The move comes despite growing signs that the decline in case numbers in Germany is flattening out again and even rising in some areas. Germany’s Education Minister, Anja Karliczek, has defended the decision to reopen schools, saying younger children in particular benefit from learning together in groups.
In the Asia-Pacific region, New Zealand will remove remaining coronavirus restrictions from Auckland on Monday after an outbreak discovered in the largest city fades.
Serum Institute of India asked for patience from foreign governments awaiting their supply of shots, saying it had been directed to prioritize India’s requirements. Meanwhile, the state of Maharashtra, home to the country’s financial hub Mumbai, imposed new lockdowns in some areas.
Japan will only receive limited doses of vaccines for the first months of the rollout and shots for the elderly will be distributed gradually, the country’s inoculation chief said.
The Philippines and Thailand have approved Sinovac Biotech’s vaccine for emergency use, while Malaysia moved up its inoculation drive by two days.
In the Americas, Argentina’s drug regulator has authorized the emergency use of Sinopharm’s vaccine ahead of an expected delivery of one million doses of the Chinese-made vaccine.
In the Middle East, Palestinians in Gaza began a limited vaccination program after receiving doses donated by Russia and the United Arab Emirates.
Israel reopened swaths of its economy including malls and leisure facilities, saying the start of a return to routine was enabled by vaccines administered to almost half the population.
In Africa, South Africa remained the hardest-hit country on the continent, with more than 1.5 million reported cases of COVID-19 and more than 49,000 recorded deaths.
The head of the World Health Organization urged Tanzania to share information on its measures to combat the pandemic, saying the authorities there had repeatedly ignored his requests.
-From The Associated Press and Reuters, last updated at 11:15 a.m. ET